267 related articles for article (PubMed ID: 26492161)
21. Assessment of RANTES levels as the indicators of plaque vulnerability in rabbit models of atherosclerosis.
Lv YB; Jing J; Li JM; Zhong JP; Fang L; Yang B
Pathol Res Pract; 2014 Dec; 210(12):1031-7. PubMed ID: 25155378
[TBL] [Abstract][Full Text] [Related]
22. Morphological features of coronary plaques in WHHLMI rabbits (Oryctolagus cuniculus), an animal model for familial hypercholesterolemia.
Yamada S; Koike T; Nakagawa T; Kuniyoshi N; Ying Y; Itabe H; Yamashita A; Asada Y; Shiomi M
Exp Anim; 2017 May; 66(2):145-157. PubMed ID: 28025424
[TBL] [Abstract][Full Text] [Related]
23. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
[TBL] [Abstract][Full Text] [Related]
24. How do we prevent the vulnerable atherosclerotic plaque from rupturing? Insights from in vivo assessments of plaque, vascular remodeling, and local endothelial shear stress.
Andreou I; Antoniadis AP; Shishido K; Papafaklis MI; Koskinas KC; Chatzizisis YS; Coskun AU; Edelman ER; Feldman CL; Stone PH
J Cardiovasc Pharmacol Ther; 2015 May; 20(3):261-75. PubMed ID: 25336461
[TBL] [Abstract][Full Text] [Related]
25. Vulnerable plaque and vulnerable blood: Two critical factors for spontaneous atherothrombosis in mouse models.
Ouweneel AB; Verwilligen RAF; Van Eck M
Atherosclerosis; 2019 May; 284():160-164. PubMed ID: 30913516
[TBL] [Abstract][Full Text] [Related]
26. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
[TBL] [Abstract][Full Text] [Related]
27. The role of an experimental model of atherosclerosis: apoE-knockout mice in developing new drugs against atherogenesis.
Jawien J
Curr Pharm Biotechnol; 2012 Oct; 13(13):2435-9. PubMed ID: 22280417
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal Stem Cells Stabilize Atherosclerotic Vulnerable Plaque by Anti-Inflammatory Properties.
Wang SS; Hu SW; Zhang QH; Xia AX; Jiang ZX; Chen XM
PLoS One; 2015; 10(8):e0136026. PubMed ID: 26288013
[TBL] [Abstract][Full Text] [Related]
29. Plaque-associated vasa vasorum in aged apolipoprotein E-deficient mice exhibit proatherogenic functional features in vivo.
Rademakers T; Douma K; Hackeng TM; Post MJ; Sluimer JC; Daemen MJ; Biessen EA; Heeneman S; van Zandvoort MA
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):249-56. PubMed ID: 23241413
[TBL] [Abstract][Full Text] [Related]
30. Mast cells mediate neutrophil recruitment during atherosclerotic plaque progression.
Wezel A; Lagraauw HM; van der Velden D; de Jager SC; Quax PH; Kuiper J; Bot I
Atherosclerosis; 2015 Aug; 241(2):289-96. PubMed ID: 26062988
[TBL] [Abstract][Full Text] [Related]
31. Destabilizing role of cathepsin S in murine atherosclerotic plaques.
Rodgers KJ; Watkins DJ; Miller AL; Chan PY; Karanam S; Brissette WH; Long CJ; Jackson CL
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):851-6. PubMed ID: 16410454
[TBL] [Abstract][Full Text] [Related]
32. Practical assessment of the quantification of atherosclerotic lesions in apoE⁻/⁻ mice.
Lin Y; Bai L; Chen Y; Zhu N; Bai Y; Li Q; Zhao S; Fan J; Liu E
Mol Med Rep; 2015 Oct; 12(4):5298-306. PubMed ID: 26239265
[TBL] [Abstract][Full Text] [Related]
33. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K
Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009
[TBL] [Abstract][Full Text] [Related]
34. [Expressions of fractalkine and CD11c on common carotid artery atherosclerotic plaques from apoE(-/-) mice].
Xu ZX; Lu LM; Zhang YG; Zhang GB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Oct; 35(5):519-23. PubMed ID: 24183040
[TBL] [Abstract][Full Text] [Related]
35. In vivo fluorescence-mediated tomography imaging demonstrates atorvastatin-mediated reduction of lesion macrophages in ApoE-/- mice.
Larmann J; Frenzel T; Schmitz M; Hahnenkamp A; Demmer P; Immenschuh S; Tietge UJ; Bremer C; Theilmeier G
Anesthesiology; 2013 Jul; 119(1):129-41. PubMed ID: 23559030
[TBL] [Abstract][Full Text] [Related]
36. Suxiaojiuxin pill enhances atherosclerotic plaque stability by modulating the MMPs/TIMPs balance in ApoE-deficient mice.
Zhang J; Zhuang P; Lu Z; Zhang M; Zhang T; Zhang Y; Wang J; Liu D; Tong Y
J Cardiovasc Pharmacol; 2014 Aug; 64(2):120-6. PubMed ID: 24621651
[TBL] [Abstract][Full Text] [Related]
37. Effects of mechanical properties and atherosclerotic artery size on biomechanical plaque disruption - mouse vs. human.
Riou LM; Broisat A; Ghezzi C; Finet G; Rioufol G; Gharib AM; Pettigrew RI; Ohayon J
J Biomech; 2014 Mar; 47(4):765-72. PubMed ID: 24491495
[TBL] [Abstract][Full Text] [Related]
38. Intrauterine exposure to maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life.
Alkemade FE; Gittenberger-de Groot AC; Schiel AE; VanMunsteren JC; Hogers B; van Vliet LS; Poelmann RE; Havekes LM; Willems van Dijk K; DeRuiter MC
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2228-35. PubMed ID: 17656671
[TBL] [Abstract][Full Text] [Related]
39. Endothelial-to-Mesenchymal Transition: A Potential Mechanism for Atherosclerosis Plaque Progression and Destabilization.
Li A; Peng W; Xia X; Li R; Wang Y; Wei D
DNA Cell Biol; 2017 Nov; 36(11):883-891. PubMed ID: 28920704
[TBL] [Abstract][Full Text] [Related]
40. Noninvasive assessment of atherosclerotic plaque progression in ApoE-/- mice using susceptibility gradient mapping.
Makowski MR; Varma G; Wiethoff AJ; Smith A; Mattock K; Jansen CH; Warley A; Taupitz M; Schaeffter T; Botnar RM
Circ Cardiovasc Imaging; 2011 May; 4(3):295-303. PubMed ID: 21422166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
